—DLR
— • —
$188.87
P/E
49.97
PEG
—
FCF Yield
—
Rev Growth YoY
+1004.0% YoY
Gross Margin
5799.0%
Health Score
5/10
D/E Ratio
0.82
Confidence
LOW
Business Snapshot
The ticker and exchange identifiers were not supplied in this payload, which limits contextual framing. Based on available financial ratios — a Price/Sales of 10.58x, a P/E of 49.97x, and extraordinary reported revenue growth of 1,004% year-over-year — this appears to be a high-growth, likely early-stage or recently-transformed company. Without a confirmed market capitalisation figure, a definitive cap-tier classification cannot be assigned, though the valuation profile and growth characteristics are consistent with a small- to mid-cap operator.
Financial Health
**Score: 5/10** The company's reported gross margin of 5,799% and net margin of 2,141% are figures that appear statistically anomalous and likely reflect an extremely small revenue base, which can cause percentage-based margin metrics to become mathematically distorted rather than genuinely indicative of operational excellence. Debt/equity of 0.82x is manageable and within a range that does not raise immediate solvency concerns...
Risk Assessment
- **VALUATION: P/E of 49.97x is approximately double the sector average of 25x, leaving limited margin of safety if growth disappoints.** - **DATA INTEGRITY: Gross margin of 5,799% and net margin of 2,141% are almost certainly distorted by an abnormally small revenue base, making margin analysis unreliable.** - **CASH FLOW: Free cash flow is unavailable, preventing any assessment of whether earnings are backed by real cash generation.** - **EARNINGS CONSISTENCY: The company beat analyst estimates in only 1 of the last 4 quarters, signalling unreliable execution against expectations.** - **TECHNICALS: A confirmed death cross (50-day MA crossing below 200-day MA) is in effect, alongside a bearish MACD signal — both are classically negative momentum indicators.** ---...